Related Experiment Video
Updated: Jun 4, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
A pilot study on the effectiveness of anticipatory grief therapy for elderly facing the end of life
Joanna Oi-Yue Cheng1, Raymond Lo, Faye Chan
1S.H. Ho Centre for Gerontology and Geriatrics and Department of Medicine and Therapeutics, Chinese University of Hong Kong, Cadenza, Room 104, Meng Wah Complex, Pokfulam, Hong Kong. chengoiyue@cuhk.edu.hk
Abstract:
This pilot study evaluates the benefits of anticipatory grief therapy (AGT) for day hospice patients and long-term care (LTC) residents with cancer and non-malignant chronic diseases. Twenty-six elderly people (69.2 percent female; average age 81.8 years) participated in experiential, expressive activities and discussions during AGT. The McGill Quality of Life Questionnaire-Hong Kong version and the 15-item Geriatrics Depression Scale (Chinese version) were administered immediately before and after AGT, and at a four-week follow-up. Focus groups were held to collect qualitative feedback. Significant post-AGT improvements were found in physical (Z = -2.12, p < 0.05), psychological (Z = -2.22, p < 0.05), and total quality of life measures (Z = -2.66, p < 0.01), and in depression levels (Z = -2.49, p < 0.05). Emergent qualitative themes included grief and existential concerns, pros and cons of reminiscence, reflection and affirmation of meaning through expressive art, perceived benefits of AGT, and comments and suggestions for improving AGT in the future. We conclude that AGT delivered in both day hospice and LTC settings could be acceptable, feasible, and useful for elderly people facing the end of life.
Related Concept Videos
Bonanno's Theory of Grieving
Resilience
The resilience...
Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
Coping Strategies: Emotion Focused
Pharmacodynamics in Geriatric Patients: Effects of Age
Ethical Dilemmas II